392
Views
3
CrossRef citations to date
0
Altmetric
Author's View

Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma

, , , , , , & show all
Article: e25123 | Received 08 May 2013, Accepted 21 May 2013, Published online: 28 May 2013

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.